GREET MEDICAL PRACTICE — All Prescriptions & Medications — Page 8
Practice Code: M85735 | BIRMINGHAM, B11 3ND
Showing results 351-400 of 423
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Other individually formulated bought in preparations | 16 | 716 | £194 | -51.0% ▼ |
| 16 | 205 | £110 | +54.0% ▲ | |
| Cinnarizine | 15 | 2,100 | £94 | -67.9% ▼ |
| Topiramate | 15 | 1,076 | £486 | -91.6% ▼ |
| Insulin detemir | 15 | 195 | £1.6K | -80.8% ▼ |
| Glimepiride | 15 | 1,086 | £31 | -83.7% ▼ |
| Alfuzosin hydrochloride | 15 | 906 | £360 | -79.0% ▼ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 15 | 36.0K | £1.1K | -43.5% ▼ |
| Specialist food replacer rolls/baguettes (0913271) | 15 | 22.5K | £280 | -37.9% ▼ |
| Celecoxib | 15 | 900 | £37 | -77.3% ▼ |
| Methotrexate | 15 | 336 | £20 | -95.4% ▼ |
| Azelastine hydrochloride | 15 | 120 | £91 | +26.2% ▲ |
| Fluvastatin sodium | 14 | 1,008 | £129 | -39.5% ▼ |
| Alimemazine tartrate | 14 | 2,700 | £2.5K | +8.3% ▲ |
| Hydrocortisone | 14 | 1,530 | £83 | -83.4% ▼ |
| RtS 1.4 - 2 kcal/g dessert style (milk based) (0913011) | 14 | 50.5K | £582 | -63.3% ▼ |
| Pdr disc/non ACBS protein SfI metabolic condition (0913445) | 14 | 16.2K | £10.6K | +117.2% ▲ |
| Benzoyl peroxide | 14 | 490 | £77 | -0.7% vs avg |
| 14 | 160 | £245 | +27.9% ▲ | |
| 14 | 76 | £181 | +75.1% ▲ | |
| 14 | 485 | £13 | -44.3% ▼ | |
| Amisulpride | 13 | 1,170 | £427 | -81.5% ▼ |
| Metoclopramide hydrochloride | 13 | 476 | £15 | -84.3% ▼ |
| Zolmitriptan | 13 | 102 | £506 | -80.0% ▼ |
| Pizotifen malate | 13 | 700 | £28 | -84.2% ▼ |
| Erythromycin ethylsuccinate | 13 | 1,228 | £207 | -44.3% ▼ |
| Combined ethinylestradiol 20mcg | 13 | 279 | £90 | -75.1% ▼ |
| Sodium chloride | 13 | 11.7K | £2.3K | -45.1% ▼ |
| Other calcium supplement preparations | 13 | 780 | £349 | +73.4% ▲ |
| RtS 1.4-1.5kcal/ml energy & higher protein liquid (0913141) | 13 | 840 | £1.9K | +34.1% ▲ |
| Clindamycin phosphate | 13 | 780 | £223 | -21.0% ▼ |
| Valsartan/amlodipine | 12 | 336 | £229 | +9.4% ▲ |
| Glycopyrronium bromide | 12 | 540 | £470 | -67.8% ▼ |
| Levocetirizine | 12 | 360 | £46 | -23.0% ▼ |
| Guanfacine | 12 | 364 | £759 | -53.3% ▼ |
| Vildagliptin | 12 | 672 | £205 | -17.3% ▼ |
| Testosterone | 12 | 360 | £430 | -84.3% ▼ |
| Medroxyprogesterone acetate | 12 | 12 | £69 | -90.1% ▼ |
| Brinzolamide and timolol | 12 | 115 | £242 | -68.2% ▼ |
| Fluocinolone acetonide | 12 | 440 | £67 | +10.2% ▲ |
| 12 | 530 | £2.6K | -5.1% ▼ | |
| Sotalol hydrochloride | 11 | 728 | £27 | -84.4% ▼ |
| Midodrine hydrochloride | 11 | 1,084 | £269 | -77.4% ▼ |
| 11 | 15 | £654 | -96.5% ▼ | |
| Temazepam | 11 | 285 | £252 | -80.8% ▼ |
| Zuclopenthixol hydrochloride | 11 | 1,100 | £84 | -65.1% ▼ |
| Nortriptyline | 11 | 448 | £16 | -92.4% ▼ |
| Doxylamine succinate/pyridoxine hydrochloride | 11 | 334 | £476 | -0.3% vs avg |
| Oxcarbazepine | 11 | 660 | £106 | -60.7% ▼ |
| Azithromycin | 11 | 184 | £44 | -91.3% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.